{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:13:19Z","timestamp":1774516399760,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s12325-021-01987-1","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T18:58:19Z","timestamp":1638298699000},"page":"655-673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical Implications of Nicorandil Combined with Trimetazidine in Patients with Coronary Heart Disease: A Real-World Observational Study"],"prefix":"10.1007","volume":"39","author":[{"given":"Lan","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0863-3091","authenticated-orcid":false,"given":"Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"1987_CR1","first-page":"1","volume":"17","author":"L-Y Ma","year":"2020","unstructured":"Ma L-Y, Chen W-W, Gao R-L, et al. China cardiovascular diseases report 2018: an updated summary. J Geriatr Cardiol. 2020;17:1\u20138.","journal-title":"J Geriatr Cardiol"},{"key":"1987_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2261-14-38","volume":"14","author":"Y-S Lin","year":"2014","unstructured":"Lin Y-S, Liu P-H, Wu L-S, Chen Y-M, Chang C-J, Chu P-H. Major adverse cardiovascular events in adult congenital heart disease: a population-based follow-up study from Taiwan. BMC Cardiovasc Disord. 2014;14:38.","journal-title":"BMC Cardiovasc Disord"},{"key":"1987_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-016-0436-7","volume":"17","author":"I-T Tsai","year":"2017","unstructured":"Tsai I-T, Wang C-P, Lu Y-C, et al. The burden of major adverse cardiac events in patients with coronary artery disease. BMC Cardiovasc Disord. 2017;17:1.","journal-title":"BMC Cardiovasc Disord"},{"key":"1987_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.15420\/ecr.2018.26.1","volume":"14","author":"TA Rousan","year":"2019","unstructured":"Rousan TA, Thadani U. Stable angina medical therapy management guidelines: a critical review of guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence. Eur Cardiol. 2019;14:18\u201322.","journal-title":"Eur Cardiol"},{"key":"1987_CR5","first-page":"1749","volume":"130","author":"SD Fihn","year":"2014","unstructured":"Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease. Circ Am Heart Assoc. 2014;130:1749\u201367.","journal-title":"Circ Am Heart Assoc"},{"key":"1987_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: the Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020;41:407\u201377.","journal-title":"Eur Heart J"},{"key":"1987_CR7","unstructured":"Chinese Society of Cardiology, Chinese Medical Association; Editorial Board, Chinese Journal of Cardiology. Guideline for diagnosis and treatment of patients with chronic stable angina. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35:195\u2013206."},{"key":"1987_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.15420\/ecr.2018.9.2","volume":"13","author":"JM Tarkin","year":"2018","unstructured":"Tarkin JM, Kaski JC. Nicorandil and long-acting nitrates: vasodilator therapies for the management of chronic stable angina pectoris. Eur Cardiol. 2018;13:23\u20138.","journal-title":"Eur Cardiol"},{"key":"1987_CR9","first-page":"137","volume":"45","author":"MY Liu","year":"2017","unstructured":"Liu MY, Zhang LJ. [Impact of trimetazidine pre-treatment on 5-hydroxytryptamine and serotonin transporter in rats with experimental myocardial infarction and depression]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45:137\u201341.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"1987_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","volume":"15","author":"R Ferrari","year":"2018","unstructured":"Ferrari R, Camici PG, Crea F, et al. A \u201cdiamond\u201d approach to personalized treatment of angina. Nat Rev Cardiol. 2018;15:120\u201332.","journal-title":"Nat Rev Cardiol"},{"key":"1987_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/eurheartj\/ehy504","volume":"40","author":"R Ferrari","year":"2019","unstructured":"Ferrari R, Pavasini R, Camici PG, et al. Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment. Eur Heart J. 2019;40:190\u20134.","journal-title":"Eur Heart J"},{"key":"1987_CR12","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3389\/fphar.2019.01112","volume":"10","author":"H Xu","year":"2019","unstructured":"Xu H, Zou J, Ye X, et al. Impacts of clinical pharmacist intervention on the secondary prevention of coronary heart disease: a randomized controlled clinical study. Front Pharmacol. 2019;10:1112.","journal-title":"Front Pharmacol"},{"key":"1987_CR13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jacc.2019.03.013","volume":"74","author":"JW Jukema","year":"2019","unstructured":"Jukema JW, Szarek M, Zijlstra LE, et al. Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial. J Am Coll Cardiol. 2019;74:1167\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"1987_CR14","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","volume":"359","author":"IONA Study Group","year":"2002","unstructured":"IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002;359:1269\u201375.","journal-title":"Lancet"},{"key":"1987_CR15","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S0140-6736(20)31790-6","volume":"396","author":"R Ferrari","year":"2020","unstructured":"Ferrari R, Ford I, Fox K et al. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial. Lancet 2020;396:830\u201338.","journal-title":"The Lancet"},{"key":"1987_CR16","doi-asserted-by":"crossref","unstructured":"IONA Study Group. Impact of nicorandil in angina: subgroup analyses. Heart. 2004;90:1427\u201330.","DOI":"10.1136\/hrt.2003.026310"},{"key":"1987_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1253\/circj.CJ-09-0649","volume":"74","author":"S Horinaka","year":"2010","unstructured":"Horinaka S, Yabe A, Yagi H, et al. Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study. Circ J. 2010;74:503\u20139.","journal-title":"Circ J"},{"key":"1987_CR18","first-page":"2339","volume":"13","author":"J Li","year":"2020","unstructured":"Li J, Li Y. Effects of nicorandil combined with trimetazidine on endothelial cell microparticles, endothelial cell-specific molecule-1 and high-sensitivity C-reactive protein in patients with acute myocardial infarction after PCI. Int J Clin Exp Med. 2020;13:2339\u201346.","journal-title":"Int J Clin Exp Med"},{"key":"1987_CR19","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.clinthera.2019.08.008","volume":"41","author":"H Zhu","year":"2019","unstructured":"Zhu H, Xu X, Fang X, et al. Effects of the antianginal drugs ranolazine, nicorandil, and ivabradine on coronary microvascular function in patients with nonobstructive coronary artery disease: a meta-analysis of randomized controlled trials. Clin Ther. 2019;41:2137-2152.e12.","journal-title":"Clin Ther"},{"key":"1987_CR20","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4244\/EIJV9I9A178","volume":"9","author":"A Hirohata","year":"2014","unstructured":"Hirohata A, Yamamoto K, Hirose E, et al. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study. EuroIntervention. 2014;9:1050\u20136.","journal-title":"EuroIntervention"},{"issue":"34","key":"1987_CR21","first-page":"2949","volume":"2013","author":"TF Members","year":"2013","unstructured":"Members TF, Montalescot G, Sechtem U, et al. ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;2013(34):2949\u20133003.","journal-title":"Eur Heart J"},{"key":"1987_CR22","unstructured":"National Clinical Guidelines Centre. Stable angina: methods, evidence & guidance. NICE. https:\/\/www.nice.org.uk\/guidance\/cg126\/evidence\/full-guideline-183176605. Accessed 28 Oct 2021."},{"key":"1987_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/1742395310369018","volume":"6","author":"R Horne","year":"2010","unstructured":"Horne R, Clatworthy J, Hankins M, ASCOT Investigators. High adherence and concordance within a clinical trial of antihypertensives. Chronic Illn. 2010;6:243\u201351.","journal-title":"Chronic Illn"},{"key":"1987_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2017.07.011","volume":"91","author":"SS Allemann","year":"2017","unstructured":"Allemann SS, Nieuwlaat R, Navarro T, Haynes B, Hersberger KE, Arnet I. Congruence between patient characteristics and interventions may partly explain medication adherence intervention effectiveness: an analysis of 190 randomized controlled trials from a Cochrane systematic review. J Clin Epidemiol. 2017;91:70\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1987_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/HYPERTENSIONAHA.111.171074","volume":"58","author":"HAW van Onzenoort","year":"2011","unstructured":"van Onzenoort HAW, Menger FE, Neef C, et al. Participation in a clinical trial enhances adherence and persistence to treatment: a retrospective cohort study. Hypertension. 2011;58:573\u20138.","journal-title":"Hypertension"},{"key":"1987_CR26","first-page":"3769152","volume":"2016","author":"U Barbero","year":"2016","unstructured":"Barbero U, D\u2019Ascenzo F, Nijhoff F, et al. Assessing risk in patients with stable coronary disease: when should we intensify care and follow-up? Results from a meta-analysis of observational studies of the COURAGE and FAME Era. Scientifica (Cairo). 2016;2016:3769152.","journal-title":"Scientifica (Cairo)"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01987-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01987-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01987-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T08:48:10Z","timestamp":1643359690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01987-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1987"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01987-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"assertion":[{"value":"22 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}